Alastair MacKinnon

Chief Executive Officer at

Dark Blue Therapeutics Ltd.

55 year

55 connections

Health Technology

Consumer Services

Commercial Services

Profile

Alastair Graham MacKinnon was the founder of Mereo BioPharma Group Plc, founded in 2015, where the title held was Chief Portfolio Management & Pipeline Strategy from 2021 to 2022.
Current jobs include Chief Executive Officer & Director at Dark Blue Therapeutics Ltd. since 2022; Director at Mereo BioPharma 3 Ltd., Mereo BioPharma 2 Ltd. since 2015, and Mereo BioPharma 4 Ltd. since 2017; and Member at The Royal College of Surgeons of Edinburgh.
Former job includes Partner at Phase4 Partners Ltd. from 2014 to 2022.
Education includes undergraduate and doctorate degrees from King's College London.

Alastair MacKinnon active positions

Companies	Position	Start
The Royal College of Surgeons of Edinburgh The Royal College of Surgeons of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
Mereo Biopharma 3 Ltd. Mereo Biopharma 3 Ltd. BiotechnologyHealth Technology Develops bio pharm products	Director/Board Member	-
Mereo BioPharma 2 Ltd. Mereo BioPharma 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and experimental development for biotechnology	Director/Board Member	2015-06-29
Mereo BioPharma 4 Ltd. Mereo BioPharma 4 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnological research and development services	Director/Board Member	2017-10-23
Dark Blue Therapeutics Ltd. Dark Blue Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops precision oncology medicines	Chief Executive Officer	2022-07-31

All active positions of Alastair MacKinnon

Former positions of Alastair MacKinnon

Companies	Position	End
MEREO BIOPHARMA GROUP PLC	Founder	2022-07-31
Phase4 Partners Ltd. Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It Participates in early and later stage capital requirements with an investment size of USD 15 - 30 million.	Private Equity Investor	2022-02-27

See the detail of Alastair MacKinnon's experience

Training of Alastair MacKinnon

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Alastair MacKinnon's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
Phase4 Partners Ltd. Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It Participates in early and later stage capital requirements with an investment size of USD 15 - 30 million.	Finance
King's College London King's College London Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The Royal College of Surgeons of Edinburgh The Royal College of Surgeons of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Mereo BioPharma Group Plc Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company	Health Technology
Mereo Biopharma 3 Ltd. Mereo Biopharma 3 Ltd. BiotechnologyHealth Technology Develops bio pharm products	Health Technology
Mereo BioPharma 2 Ltd. Mereo BioPharma 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and experimental development for biotechnology	Commercial Services
Mereo BioPharma 4 Ltd. Mereo BioPharma 4 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnological research and development services	Commercial Services
Dark Blue Therapeutics Ltd. Dark Blue Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops precision oncology medicines	Health Technology